Cargando…

Low urine pH predicts new onset of diabetes mellitus during a 10‐year period in men: BOREAS‐DM1 study

AIMS/INTRODUCTION: A low level of urine pH (U‐pH) has been reported to be associated with metabolic disorders. However, the relationship between the incidence of diabetes mellitus and U‐pH has not yet been fully addressed. MATERIALS AND METHODS: We investigated the relationship between U‐pH and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higashiura, Yukimura, Tanaka, Marenao, Furuhashi, Masato, Koyama, Masayuki, Ohnishi, Hirofumi, Numata, Keita, Hisasue, Takashi, Hanawa, Nagisa, Moniwa, Norihito, Miura, Tetsuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610131/ https://www.ncbi.nlm.nih.gov/pubmed/32351012 http://dx.doi.org/10.1111/jdi.13284

Ejemplares similares

High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects
por: Takahashi, Satoko, et al.
Publicado: (2021)

Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
por: Saito, Norie, et al.
Publicado: (2021)

Increased LDL-cholesterol level is associated with deterioration of renal function in males
por: Osanami, Arata, et al.
Publicado: (2022)

Differential regulation of hypoxanthine and xanthine by obesity in a general population
por: Furuhashi, Masato, et al.
Publicado: (2020)

Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria
por: Tanaka, Marenao, et al.
Publicado: (2020)

High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population
por: Higashiura, Yukimura, et al.
Publicado: (2022)

Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication
por: Furuhashi, Masato, et al.
Publicado: (2022)

Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals
por: Tanaka, Marenao, et al.
Publicado: (2022)

Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary Artery
por: Numaguchi, Ryosuke, et al.
Publicado: (2019)

Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication
por: Furuhashi, Masato, et al.
Publicado: (2022)

Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor
por: Furuhashi, Masato, et al.
Publicado: (2016)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
por: Tanaka, Marenao, et al.
Publicado: (2017)

Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
por: Furuhashi, Masato, et al.
Publicado: (2017)

Peace, Rude Boreas
Publicado: (1868)

Peace, Rude Boreas
Publicado: (1868)

Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data
por: Murakami, Naoto, et al.
Publicado: (2017)

Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease
por: Miyamori, Daisuke, et al.
Publicado: (2023)

Insulin Resistance is Associated with Longitudinal Changes of Cardiac Repolarization Heterogeneity in Apparently Healthy Subjects
por: Matsumoto, Tamaki, et al.
Publicado: (2019)

Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters
por: Furuhashi, Masato, et al.
Publicado: (2016)

Antiatherosclerotic Phenotype of Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass Grafting
por: Mikami, Takuma, et al.
Publicado: (2021)

Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population
por: Ishimura, Shutaro, et al.
Publicado: (2013)

Inhibition of Batrachochytrium dendrobatidis Caused by Bacteria Isolated from the Skin of Boreal Toads, Anaxyrus (Bufo) boreas boreas, from Grand Teton National Park, Wyoming, USA
por: Park, Shawna T, et al.
Publicado: (2014)

Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats
por: Kuno, Atsushi, et al.
Publicado: (2020)

Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19
por: Furuhashi, Masato, et al.
Publicado: (2020)

Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation
por: Ota, Hideki, et al.
Publicado: (2012)

Characterization of prehospital time delay in primary percutaneous coronary intervention for acute myocardial infarction: analysis of geographical infrastructure-dependent and -independent components
por: Oyatani, Keisuke, et al.
Publicado: (2023)

Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction
por: Okazaki, Yusuke, et al.
Publicado: (2014)

Reply to the comments of Naharci et al. on “Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals”
por: Tanaka, Marenao, et al.
Publicado: (2022)

Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury
por: Fuseya, Takahiro, et al.
Publicado: (2017)

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease
por: Furuhashi, Masato, et al.
Publicado: (2011)

Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population
por: Fuseya, Takahiro, et al.
Publicado: (2014)

Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
por: Furuhashi, Masato, et al.
Publicado: (2020)

Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
por: Furuhashi, Masato, et al.
Publicado: (2020)

Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy
por: Furuhashi, Masato, et al.
Publicado: (2022)

Lipid Chaperones and Metabolic Inflammation
por: Furuhashi, Masato, et al.
Publicado: (2011)

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
por: Furuhashi, Masato, et al.
Publicado: (2015)

Toe Grip strength declines earlier than hand grip strength and knee extension strength in community-dwelling older men: a cross sectional study
por: Miura, Sayo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r00h2hlhchnbrtl3it2kdid3od